Academy Capital Management Lowered Its Valeant Pharmaceuticals (VRX) Holding; Dial Has 1 Sentiment

August 3, 2017 - By Peter Erickson

China Distance Education Holdings Limited is a holding company. The company has market cap of $231.52 million. The Firm is engaged in providing online and offline education services, and selling related products in the People’s Republic of China . It has a 9.16 P/E ratio. The Company’s divisions include online education services, business start-up training services and the sale of learning simulation software.

Academy Capital Management Inc decreased Valeant Pharmaceuticals (VRX) stake by 17.4% reported in 2016Q4 SEC filing. Academy Capital Management Inc sold 113,065 shares as Valeant Pharmaceuticals (VRX)’s stock declined 15.71%. The Academy Capital Management Inc holds 536,894 shares with $7.80 million value, down from 649,959 last quarter. Valeant Pharmaceuticals now has $5.43B valuation. The stock declined 4.69% or $0.77 reaching $15.65 per share. About 10.13M shares traded. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has declined 48.51% since August 3, 2016 and is downtrending. It has underperformed by 65.21% the S&P500.

Among 26 analysts covering Valeant Pharmaceuticals Intl (NYSE:VRX), 6 have Buy rating, 3 Sell and 17 Hold. Therefore 23% are positive. Valeant Pharmaceuticals Intl had 114 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Hold” rating by Deutsche Bank given on Tuesday, October 20. The firm has “Neutral” rating by Goldman Sachs given on Monday, November 2. The rating was maintained by Deutsche Bank with “Hold” on Friday, October 14. The firm has “Underweight” rating by Piper Jaffray given on Tuesday, March 15. RBC Capital Markets maintained it with “Sector Perform” rating and $22 target in Tuesday, February 14 report. Mizuho maintained the shares of VRX in report on Tuesday, June 20 with “Underperform” rating. The firm earned “Buy” rating on Wednesday, June 28 by Cantor Fitzgerald. On Wednesday, March 16 the stock rating was maintained by Stifel Nicolaus with “Buy”. On Wednesday, March 16 the stock rating was maintained by Jefferies with “Buy”. The stock has “Neutral” rating by Mizuho on Friday, October 9.

Analysts await Valeant Pharmaceuticals Intl Inc (NYSE:VRX) to report earnings on August, 8 before the open. They expect $0.96 EPS, down 31.43% or $0.44 from last year’s $1.4 per share. VRX’s profit will be $333.09M for 4.08 P/E if the $0.96 EPS becomes a reality. After $2.80 actual EPS reported by Valeant Pharmaceuticals Intl Inc for the previous quarter, Wall Street now forecasts -65.71% negative EPS growth.

Investors sentiment decreased to 0.78 in 2016 Q4. Its down 0.10, from 0.88 in 2016Q3. It fall, as 82 investors sold VRX shares while 87 reduced holdings. 49 funds opened positions while 82 raised stakes. 193.03 million shares or 13.22% less from 222.43 million shares in 2016Q3 were reported. Chou Associates holds 9.1% in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) or 1.96 million shares. Archford Cap Strategies Limited Liability Company accumulated 57 shares. Prudential Public Lc invested in 0% or 75,000 shares. Retail Bank Of Montreal Can accumulated 4.08 million shares or 0.07% of the stock. D E Shaw & reported 1.66M shares. Trexquant Investment LP holds 20,600 shares. State Of Wisconsin Invest Board reported 255,756 shares stake. Fincl Bank Of America De holds 0.01% of its portfolio in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) for 4.58M shares. Millennium Management Ltd Liability invested in 0.04% or 1.34 million shares. Teacher Retirement Systems Of Texas accumulated 0.02% or 225,900 shares. 40,470 are owned by Qs Invsts Ltd Limited Liability Company. 276 are owned by Thompson Davis & Communication Inc. World Asset Inc invested in 0.01% or 21,174 shares. Northwestern Mutual Wealth Management reported 0.01% in Valeant Pharmaceuticals Intl Inc (NYSE:VRX). Alyeska Inv Lp owns 1.51 million shares.

Since March 13, 2017, it had 3 buys, and 1 insider sale for $166.26 million activity. The insider Herendeen Paul bought $257,280. On Tuesday, March 14 ValueAct Holdings – L.P. bought $32.47 million worth of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) or 3.00M shares. 20,000 Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares with value of $278,000 were bought by DE SCHUTTER RICHARD U. Shares for $199.26M were sold by Pershing Square Capital Management – L.P..

Herald Investment Management Ltd holds 1% of its portfolio in China Distance Education Hldgs Ltd (ADR) for 206,473 shares. Sensato Investors Llc owns 356,651 shares or 0.69% of their US portfolio. Moreover, Jupiter Asset Management Ltd has 0.34% invested in the company for 818,424 shares. The Bermuda-based Fil Ltd has invested 0.05% in the stock. Van Berkom & Associates Inc., a Quebec – Canada-based fund reported 78,416 shares.

About 504 shares traded. China Distance Education Hldgs Ltd (ADR) (DL) has declined 28.21% since August 3, 2016 and is downtrending. It has underperformed by 44.91% the S&P500.